From: Patients’ preferences for osteoporosis drug treatment: a discrete-choice experiment
Efficacy in reducing the risk of future fractures | 20% |
30% | |
40% | |
50% | |
Possible side effects (affecting one in 50 patients) | Gastrointestinal disorders |
Flu-like symptoms | |
Skin reactions | |
Mode of administration | Oral tablet |
Subcutaneous injection | |
Intravenous injection | |
Frequency of administration | Weekly |
Monthly | |
Every 3 months | |
Every 6 months | |
Yearly | |
Cost to you (per month) | €5 |
€15 | |
€25 | |
€40 | |
€60 |